Empagliflozin/linagliptin
(Redirected from Glyxambi)
Empagliflozin/linagliptin is a combination medication used in the treatment of Type 2 diabetes. It contains two active ingredients, empagliflozin and linagliptin, which work together to control blood sugar levels in people with diabetes.
Mechanism of Action[edit | edit source]
Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion and lower blood glucose levels. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones, which help to control blood sugar by increasing insulin release, especially after a meal.
Indications[edit | edit source]
Empagliflozin/linagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes who are not adequately controlled on a regimen containing empagliflozin or linagliptin, or in patients already being treated with both empagliflozin and linagliptin.
Side Effects[edit | edit source]
Common side effects of empagliflozin/linagliptin include urinary tract infections, upper respiratory tract infections, and increased urination. Serious side effects may include hypoglycemia, acute kidney injury, and hypersensitivity reactions.
Contraindications[edit | edit source]
Empagliflozin/linagliptin is contraindicated in patients with a history of serious hypersensitivity reaction to empagliflozin, linagliptin, or any of the product components. It is also contraindicated in patients with severe renal impairment, end-stage renal disease, or dialysis.
Drug Interactions[edit | edit source]
Empagliflozin/linagliptin may interact with other medications, including diuretics, insulin or insulin secretagogues, and rifampin.
Dosage and Administration[edit | edit source]
The recommended dose of empagliflozin/linagliptin is one tablet taken orally once daily in the morning, with or without food.
See Also[edit | edit source]
| Empagliflozin/linagliptin Resources | ||
|---|---|---|
|
| |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
